Collectively, our data demonstrate that the progression of patients from outpatients with ascites to patients hospitalised with AD/ACLF is accompanied by an increase in bioavailable PGE2, reduced monocyte HLA-DR expression, and reduced monocyte TNFα/IL6 production. This evidence concerns the gene TNF and Alzheimer disease.